Professor Bruno Vellas
HOPITAUX DE TOULOUSE
Bruno Vellas, MD, PhD, (Toulouse, France) is Professor of Medicine and Head of Toulouse University Hospital's Department of Internal Medicine and Clinical Gerontology and Director of the Toulouse Gérontopôle. He is Chief of Alzheimer’s Disease Clinical Research Centre at the Toulouse University Hospital and was Founder of the European Alzheimer’s Disease Consortium (EADC). He is member of the INSERM Unit 1027 on Aging (National Institute on Health and Medical Research).
For more than 20 years now he has been involved in large trials on Alzheimer's disease and on Frailty. Professor Vellas has published over 480 articles in the field and especially on Alzheimer and disease modifying treatment, Frailty, Sarcopenia Research. He was nominated «Officier de la Légion d’Honneur» and is Corresponding member of the French National Academy of Medicine.
Prof VELLAS served as President of the International Association of Gerontology and Geriatrics (IAGG) from 2009 to 2013 and is currently Director of IAGG’s Global Aging Research Network (IAGG GARN).
Professor Alan Sinclair
Professor Alan Sinclair is the Director of the Foundation for Diabetes Research in Older People at Diabetes Frail Ltd, a not-for-profit research organisation established in 2014. This Foundation takes forward the work of the Institute of Diabetes for Older People (IDOP) which was previously established by Professor Sinclair in 2008. Alan is an international expert in diabetes and geriatrics and was Professor of Medicine at the University of Bedfordshire and Dean at the Bedfordshire & Hertfordshire Postgraduate Medical School, as well as being a consultant diabetologist and geriatrician at the Luton & Dunstable University Hospital, Bedfordshire, UK.
Professor Sinclair has provided advice for the UK NICE organisation and the UK Department of Health on matters relating to diabetes in older people. He has produced international guidelines on diabetes care for older people and more recently co-led an IDF initiative in this area. Professor Sinclair was Academic Director of the EUGMS (European Union Geriatric Medicine Society) between 2001 and 2005. He has significant interests in ageing, frailty and sarcopaenia as well as nutrition, stroke illness, and cognitive dysfunction/Alzheimer’s disease. Alan has been designated a WHO Expert in Diabetes. He is the author of many papers in the areas of geriatrics, nutrition and diabetes. He is the author of the first textbook on diabetes in old age, Diabetes in Old Age (Wiley-Blackwell), the fourth edition of which is currently in preparation.
Alan is involved in four leading EU-funded studies in the areas of diabetes, frailty, and older people, and has led or co-led several UK-based initiatives on care home diabetes, end of life diabetes care, and diabetes and dementia.
UNIVERSITÁ CATTOLICA DEL SACRO CUORE
Prof. Bernabei is the Chair of the Department of Geriatrics, Neurosciences and Orthopaedics at the Università Cattolica del Sacro Cuore UCSC of Rome and Professor of Internal Medicine. He is the president of the Italian Network for Research on Aging and Active Longevity (Italia LONGEVA), member of the Italian National Health Council 2016), the highest Italian health advisory committee to the Ministry of Health and the Parliament, executive board member of EAMA (European Academy for Medicine on Aging). He is past president of the Italian Society of Geriatrics and Gerontology (SIGG; 2005-2007), past executive vice president of interRAI (1992-2010), former member of the Special Joint Commission (Italian Ministry of Health-Ministry of Labour) for disability in the older and related problems (2003-2005), former member of the Expert Committee of the Italian Drug Administration (AIFA; 2007-2012), and Visiting Professor at Brown University School of Medicine (Providence, RI, USA), Department of Community Health.
Prof. Bernabei's main research interests are in comprehensive geriatric assessment, models of health services for older care, sarcopenia, frailty, and pharmacoepidemiology. He developed the SAGE database at Brown University together with Prof. Vince Mor. Prof. Bernabei has acted as the PI for the EU FP5 (ADHOC) and FP7 (SHELTER) as well as for numerous national and international clinical trials.
At present, Prof. Bernabei is leader of the Managing Entity of the Sprintt Project. This project has been funded by the IMI Innovative Medicines Initiative Agency and the ultimate goals of SPRINTT are to offer efficient treatment options to physically frail, sarcopenic older persons and to ameliorate their quality of life. This result will directly contribute to the long-term sustainability and efficiency of health- and social-care systems.
Dr. Andrej Zeyfang
AGAPLESION BETHESDA KRANKENHAUS
Dr Andrej Zeyfang is the Head of the Department of Internal Medicine and Geriatrics in the Competence Center for Geriatric Medicine at the Agaplesion Bethesda Hospital (Stuttgart, Germany). He obtained his degree in Medicine at the Università Cattolica (Rome, Italy) and then specialized in internal medicine, clinical geriatrics and diabetology in Stuttgart (Germany).
Between 1998 and 2006, he held the appointment of Senior Doctor at the Clinic for Geriatric Rehabilitation in Aalen and at the academic hospital of the University of Ulm (Germany). Since 2002, Dr Zeyfang is the chairman of the Special Interest Groups (SIG) ‘diabetes and geriatrics’ at the German Society of Diabetes and the head of the SIG ‘Diabetes’ in the German Society of Geriatricians.
He is also a member of the Scientific Advisory Board of the German Foundation for Diabetes. Dr Zeyfang has authored more than 50 publications in peer-reviewed journals, numerous book chapters, books on geriatric medicine for students and an educational programme for older people with diabetes.
Prof. Leocadio Rodríguez Mañas
COMUNIDAD DE MADRID
Head of the Geriatric Department, Hospital Universitario de Getafe, he is Director of the Spanish Network on Aging and Frailty (RETICEF) of the Ministry of Economy and Competitiveness, Co-Director of the Toledo Study on Healthy Aging-TSHA, where the Frailty Score Index has been developed to assess frailty in community-dwelling older adults, Principal Investigator in 36 research projects, 4 of them funded by the European Commission(3 under the FP7 focused on the field of frailty in elderly people and 1 under the Second program of community action in the field of Health 2008-2013 of the DG SANCO), as previously stated. He is also participating, playing a key role, in other EU-funded projects related to frailty or ageing, like SPRINTT (funded by IMI), ACANTO and DECI (under Horizon 2020).
Prof. Rodríguez Mañas is the coordinator of the group “Frailty” of the A3 Action Group (“Prevention and early diagnosis of frailty and functional decline”) of the European Innovation Partnership on Active Healthy Aging (EIP-AHA), contact person of the Reference Site “Region of Madrid” and responsible for the two “Best Practices” supporting the designation of this Region as Reference Site, member of other Action Groups (Prescription and adherence to medical plans-A1; Falls-A2; and Integrated Care for chronic conditions-B3) of the EIP-AHA), and member of the Working Group on Health & Performance (Joint Program Innovation “More Years, Better Lives” of the European Union)..Thus, Prof. Rodriguez Mañas is fully committed in several European initiatives related to frailty and other main aims of the EIP-AHA initiative. Furthermore he has significant experience and leadership in working jointly with other consortium members as well as in the coordination and management of large joint transnational projects and initiatives, including those promoted by WHO (he is a member of the group involved in developing and running a tool for diagnosis of frailty) and the Pan-American Health Organization (as advisor for health problems in older adults). Finally he has participated as a member of the working group that released the “Consensus Document for the Detection and Management of Frailty and Falls”, launched by the Spanish Ministry of Health last June and also in making several national and international Guidelines and documents for clinical uses in older people.
Professor Mikel Izquierdo
UNIVERSIDAD PÚBLICA DE NAVARRA (PROJECT LEADER)
Head of Department of Health Sciences of the Public University of Navarra. He also holds and an appointment as a professor of Sport Biomechanics at the Centre of Studies of the Spanish Olympic Committee.
He is currently participating in the Spanish Network on Aging and Frailty (RETICEF) of the Ministry of Economy and Competitiveness and in the Mid-Frail study funded by the European Commision (FP7). He also has participated as a consultant in Physical activity in the “Consensus Document for the Detection and Management of Frailty and Falls”, launched by the Spanish Ministry of Health in 2014.